This course has expired. View available courses.
Neurology
MS & NMOSD: Optimizing the Standard of Care – Virtual Learning Series
Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
DURATION
5 hr
PROFESSION
Physician
# OF CREDITS
5.5
ACCREDITATION
MOC - Section 1, SCFHS
EXPIRY DATE
2023-02-04
Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
Faculty
Mohammed Al Jumah, MBBS,MD,FRCPC
Yaser Al Malik MD,FRCPC, ABPN, CSCN (EEG & EMG)
Hani Aggad, MD
Hajer Yousef Almudaiheem, Director of Drug Policy and Regulation at Deputyship of Therapeutic Affairs at Ministry of Health Saudi Arabia
Hany Aggad, MD
Mona Alkhawajah, MD
Hind Alnajashi, MD
Amani Alshehri, B Pharm, PharmD, BCPS, RPh, PGY2
Rola Alarieh, MSN, BSN, CNS, RN
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Discuss the clinical difference between slowly escalating treatment versus starting early with high-efficacy treatment.
- Describe the different safety profiles and monitoring requirements for the various medications used to treat multiple sclerosis.
- Optimize the management of patients with multiple sclerosis before, during, and after pregnancy.
Accreditation
#
of credits: 5.5
Duration: 5 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
5 hr
Duration
Physician
Profession
5.5
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Discuss the clinical difference between slowly escalating treatment versus starting early with high-efficacy treatment.
- Describe the different safety profiles and monitoring requirements for the various medications used to treat multiple sclerosis.
- Optimize the management of patients with multiple sclerosis before, during, and after pregnancy.
MOC - Section 1, SCFHS
ACCREDITATION
Neurology
Learning Category
General
Topic
0
Price
2023-02-04
Expiry Date
CAN-eng, MENA
Region/Language
Course Description
Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
Faculty
Mohammed Al Jumah, MBBS,MD,FRCPC
Yaser Al Malik MD,FRCPC, ABPN, CSCN (EEG & EMG)
Hani Aggad, MD
Hajer Yousef Almudaiheem, Director of Drug Policy and Regulation at Deputyship of Therapeutic Affairs at Ministry of Health Saudi Arabia
Hany Aggad, MD
Mona Alkhawajah, MD
Hind Alnajashi, MD
Amani Alshehri, B Pharm, PharmD, BCPS, RPh, PGY2
Rola Alarieh, MSN, BSN, CNS, RN
Accreditation
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
5 hr
Duration
0
Price
5.5
# of credits
